22Jan
Healthcare Antitrust – What to Expect in 2021
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the announcement of the precedent-setting settlement of the California Attorney General’s action against Sutter Health and ended with the settlement of multi-district antitrust litigation against the Blue Cross Blue Shield Association (and its member Blues)....
By:
Akerman LLP - Health Law Rx
Related
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >
UK merger control policy and practice has evolved significantly in recent years. The Competition a...
Read More >
What is the Annual Maximum Out-Of-Pocket Limit (“MOOP”)? MOOP is the most a participant must pay ...
Read More >
From the California Supreme Court’s landmark decision in Dynamex to the passage of dozens of new em...
Read More >
During FY 2018, the Japan Fair Trade Commission ("JFTC") received 321 notifications, which is the la...
Read More >
The House and Senate both returned to Raleigh this week for a three-day session, pursuant to the adj...
Read More >